nach oben

Erschienen in:

01.06.2021 | Case report

Ipilimumab/nivolumab/pembrolizumab

Immune-related hepatitis: 5 case reports

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

…

Gauci M-L, et al. Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal. Clinics and Research in Hepatology and Gastroenterology 45: No. 2, Mar 2021. Available from: URL: http://doi.org/10.1016/j.clinre.2020.06.016

Titel: Ipilimumab/nivolumab/pembrolizumab
Immune-related hepatitis: 5 case reports
Publikationsdatum: 01.06.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-97974-5